Patients with extensive-stage SCLC often respond to induction therapy, but the disease tends to progress rapidly after cytotoxic therapy ends, said Jared Weiss, MD, of the University of North Carolina ...

Still, the therapies’ modest benefit as a maintenance therapy points to how better treatments are needed for small cell lung ...

Roche’s plan to bolster Tecentriq’s position in small cell lung cancer with Jazz Pharmaceuticals’ Zepzelca has paid off. | ...

ZL-1310 earns fast track designation in extensive-stage small cell lung cancer after early trial data showed tumor shrinkage ...

With lung cancer rates among non-smokers rising, especially young East Asian women, a new study released Monday is touting ...

Teos and GSK were the last to report a new setback in TIGIT targeting for non-small cell lung cancer patients. Read why I am ...

7, 2025 — As many as one ... cells each day to keep the oxygen flowing. For many years, ... Feb. 6, 2025 — Scientists have created a new low-cost, fast response sensor to detect lung cancer ...

There is a commercial access agreement for osimertinib. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact ...

A doctor specialising in gut health has given a simple tip to reduce cholesterol and bowel cancer risk while also ... this isn’t one to skip. "Want to know a hack to up the fibre of plants?

2Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education), Zhejiang Provincial Clinical Research Center for CANCER, Cancer Center of Zhejiang ...

Introduction: Non-small cell lung cancer (NSCLC) remains a principal cause of cancer ... Furthermore, patients with elevated PSMC4 levels experience markedly reduced overall survival, disease-specific ...

Yet the biggest tragedy is the fact that most lung cancer deaths are preventable. According to Dr. Eduardo Núñez with Baystate Pulmonary Medicine, one of the reasons lung ... The five-year survival ...